Globus Medical, Inc. GMED
87.10 USD +7.52 (+9.45%)
At closeNov 5, 2026, 4:46 AM EST
87.03 -0.07 -0.08%
Pre-market · Nov 5, 4:46 AM ET
80.91 Day range 87.38
60.26 52-week range 101.40
- YTD
- -0.24%
- 1 year
- +41.26%
Analyst view
Consensus: buy
Buy
Price target (mean) 100.92 +15.9% upside
Now 87.10
- Target (low)
- 84.00
- Target (mean)
- 100.92
- Target (high)
- 125.00
Ratings (0m) 14 10 buy · 4 hold · 0 sell
- Strong buy3
- Buy7
- Hold4
- Sell0
- Strong sell0
Recommendation trend
- This month 14
- 1 month ago 15
- 2 months ago 15
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 1.20 | 1.13 – 1.26 | 1.18 | +1.4% | 792.46M | +3.0% | 13 |
| Next quarter | 1.34 | 1.31 – 1.39 | 1.28 | +4.6% | 857.71M | +3.8% | 13 |
| Current year | 5.00 | 4.97 – 5.05 | 3.98 | +25.6% | 3.20B | +8.9% | 14 |
| Next year | 5.39 | 5.10 – 5.62 | 5.00 | +7.8% | 3.39B | +6.0% | 13 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 1, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Aug 7, 2026 | Wells Fargo | Maintained | Overweight | Overweight |
| Jul 28, 2026 | UBS | Initiated | — | Neutral |
| Jul 16, 2026 | Truist Securities | Maintained | Buy | Buy |
| Jul 13, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Jul 9, 2026 | BMO Capital | Initiated | — | Outperform |
| Jul 8, 2026 | Stifel | Maintained | Hold | Hold |
| Jun 15, 2026 | Piper Sandler | Maintained | Overweight | Overweight |
| May 8, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| May 8, 2026 | Wells Fargo | Maintained | Overweight | Overweight |
| May 8, 2026 | Needham | Maintained | Buy | Buy |
| Feb 26, 2026 | Wells Fargo | Maintained | Overweight | Overweight |
| Feb 25, 2026 | Barclays | Maintained | Overweight | Overweight |
| Feb 25, 2026 | Needham | Maintained | Buy | Buy |
| Jan 30, 2026 | Needham | Upgrade | Hold | Buy |
| Jan 9, 2026 | Canaccord Genuity | Maintained | Buy | Buy |
| Jan 8, 2026 | Piper Sandler | Reiterated | Overweight | Overweight |
| Dec 17, 2025 | Canaccord Genuity | Maintained | Buy | Buy |
| Dec 17, 2025 | RBC Capital | Maintained | Outperform | Outperform |
| Dec 17, 2025 | Freedom Capital Markets | Initiated | — | Hold |
| Dec 2, 2025 | Morgan Stanley | Maintained | Overweight | Overweight |
| Nov 18, 2025 | Truist Securities | Reiterated | Buy | Buy |
| Nov 10, 2025 | Barclays | Maintained | Overweight | Overweight |
| Nov 7, 2025 | RBC Capital | Maintained | Outperform | Outperform |
| Nov 7, 2025 | Wells Fargo | Maintained | Overweight | Overweight |
| Nov 7, 2025 | B of A Securities | Upgrade | Neutral | Buy |
| Nov 7, 2025 | Truist Securities | Upgrade | Hold | Buy |
| Oct 10, 2025 | RBC Capital | Maintained | Outperform | Outperform |
| Aug 8, 2025 | Wells Fargo | Maintained | Overweight | Overweight |
| Jul 22, 2025 | Canaccord Genuity | Maintained | Buy | Buy |
